Indole Alkaloids as New Leads for the Design and Development of Novel DPP-IV Inhibitors for the Treatment of Diabetes

By  

Current Bioinformatics, Vol. 13, Iss. 2, 2018-03 ,pp. : 157-169

Bentham Science Publishers

Access to resources Recommend Favorite

Design, Synthesis, Biological Screening, and Molecular Docking Studies of Piperazine‐Derived Constrained Inhibitors of DPP‐IV for the Treatment of Type 2 Diabetes

By  

CHEMICAL BIOLOGY & DRUG DESIGN (ELECTRONIC), Vol. 85, Iss. 4, 2015-04 ,pp. : 439-446

John Wiley & Sons Inc

Access to resources Recommend Favorite

Design, Synthesis and Biological Evaluation of Imidazo[1,2‐a]pyridine Derivatives as Novel DPP‐4 Inhibitors

By  

CHEMICAL BIOLOGY & DRUG DESIGN (ELECTRONIC), Vol. 86, Iss. 4, 2015-10 ,pp. : 849-856

John Wiley & Sons Inc

Access to resources Recommend Favorite

Design, Synthesis and Biological Evaluation of Imidazo[1,2‐a]pyridine Derivatives as Novel DPP‐4 Inhibitors

By  

CHEMICAL BIOLOGY & DRUG DESIGN (ELECTRONIC), Vol. 1747-0277, Iss. 4, 2015-10 ,pp. : 849-856

John Wiley & Sons Inc

Access to resources Recommend Favorite

Quantitative Evaluation of Compliance with Recommendation for Sulfonylurea Dose Co-Administered with DPP-4 Inhibitors in Japan

By Kimura Tomomi   Shiosakai Kazuhito   Takeda Yasuaki   Takahashi Shinji   Kobayashi Masahiko   Sakaguchi Motonobu  

Pharmaceutics, Vol. 4, Iss. 3, 2012-09 ,pp. : 479-493

MDPI

Access to resources Recommend Favorite